Immunoassays Market Size, Share, Trend | Industry Report 2023
The market growth is
primarily driven by the increasing incidence of chronic and infectious
diseases and technological innovations in immunoassays instruments.
Market Size -
According to the new market research report immunoassays
market is expected to reach USD 27.15 billion by 2023 from USD 20.19 billion
in 2018, at a CAGR of 6.1%.
The
global immunoassays
market is segmented by product and
service, platform, technology, specimen type, application, end user, and region.
By
product and service, the market is segmented
into reagents and kits, analyzers, and software & services.
The
immunoassay reagents and kits segment accounted for the largest share of this
market in 2017.
Download Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436
By platform,
the market is segmented into
chemiluminescence immunoassays (CLIAs), colorimetric immunoassays (CIs),
fluorescence immunoassays (FIAs), radioimmunoassays (RIAs), and other platforms.
The CLIAs segment accounted for the largest share of the immunoassays market in
2017. The large share of this segment can primarily be attributed to the low cost and high sensitivity of CLIA-based
tests.
On the basis of technology, the immunoassays market is segmented into enzyme-linked immunosorbent assays (ELISA), rapid
tests, western blotting, enzyme-linked immunospot (ELISPOT), immuno-PCR, and
other technologies.
By
application, the immunoassays market is
classified into infectious diseases, endocrinology, bone and mineral
disorders, oncology, cardiology, hematology and blood screening, autoimmune
disorders, toxicology, neonatal screening, and other applications.
Geographic Overview -
On the basis of
region, the immunoassays market is segmented
into North America, Europe, Asia Pacific, Latin America, and the Middle East
& Africa. In 2017, North America accounted for the largest share of the
immunoassays market. The availability of government funds, growing use of
immunoassays in clinical diagnostics, and the presence of key players in the
region are driving the immunoassays market in North America.
Major industry players adopted product launches
and partnerships, collaborations, & agreements to maintain and improve
their position in the immunoassay market. Roche (Switzerland), Abbott
Laboratories (US), Siemens (Germany), and Danaher Corporation (US) have been
identified as key players in this market. These companies have a broad product
portfolio with comprehensive features and have also expanded their presence
geographically. These leaders also have products for all end users in this
market, a strong geographical presence, and they focus on continuous product
innovations.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL
60062
USA :
1-888-600-6441
newsletter@marketsandmarkets.com
Comments
Post a Comment